Christmas Special: How is DEWS III going to change your practice? With Sarah Farrant

This festive episode, we’re joined by friend of the podcast Sarah Farrant for a fast-paced, clinically focused deep dive into DEWS III and what it really means for the way you manage Dry Eye Disease.From the game-changing new definition of DED — where symptoms truly matter — to why blue light therapy is now a core part of care, Sarah cuts through the noise and delivers insights you can take straight into practice. We also unpack the emerging evidence around Demodex as a bacterial “vehicle”, the growing importance of systemic inflammation, and why meibomian gland imaging can reveal disease a decade before patients ever complain of symptoms.Eyes on tomorrow is supported by Topcon Healthcare and Thea UK.Produced by Matt Hill at Rethink Audio.----------Bonus episode for subscribers: This month Sarah shares her real-world decision-making when designing personalised lubricant and lid hygiene regimes, the expanding role of Blephaderm in periocular erythema, practical tips for building a successful dry eye clinic, and why full-face low-level light therapy is delivering results that rival blepharoplasty surgery.Pull up a mince pie, press play, and get ready to rethink dry eye.This, along with a host of CPD resources, all for just £25 per year when you subscribe at eyesontomorrow.substack.com/subscribe. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit eyesontomorrow.substack.com/subscribe

There are no comments yet.

Please log in to write the first comment.